1. Home
  2. ELVN

as 10-22-2025 3:53pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Founded: 2016 Country:
United States
United States
Employees: N/A City: BOULDER
Market Cap: 1.2B IPO Year: 2020
Target Price: $41.20 AVG Volume (30 days): 399.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.00 EPS Growth: N/A
52 Week Low/High: $13.30 - $29.79 Next Earning Date: 11-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 20.05%

ELVN Daily Stock ML Predictions

Stock Insider Trading Activity of Enliven Therapeutics Inc. (ELVN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Kintz Samuel ELVN PRESIDENT AND CEO Oct 17 '25 Sell $21.33 12,500 $266,653.75 902,892
Patel Anish ELVN CHIEF OPERATING OFFICER Oct 7 '25 Sell $20.10 6,667 $133,992.70 276,641
Hohl Benjamin ELVN CHIEF FINANCIAL OFFICER Sep 29 '25 Sell $20.40 3,250 $66,291.23 23,000
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 26 '25 Sell $20.25 4,000 $81,005.20 927,688
Kintz Samuel ELVN PRESIDENT AND CEO Sep 26 '25 Sell $20.06 3,700 $74,227.55 902,892
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 23 '25 Sell $20.03 1,500 $30,045.00 927,688
Kintz Samuel ELVN PRESIDENT AND CEO Sep 23 '25 Sell $20.03 2,800 $56,084.00 902,892
Lyssikatos Joseph P ELVN CHIEF SCIENTIFIC OFFICER Sep 19 '25 Sell $19.56 7,000 $135,697.35 927,688
Patel Anish ELVN CHIEF OPERATING OFFICER Sep 8 '25 Sell $20.24 6,667 $134,957.41 276,641
Hohl Benjamin ELVN CHIEF FINANCIAL OFFICER Aug 27 '25 Sell $20.63 3,250 $67,038.73 23,000

Share on Social Networks: